{"id":"W4283020820","doi":"10.1093/noajnl/vdac085","title":"Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology Advances","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; Cancer Research UK; Oncolytics Biotech; Mayo Clinic","keywords":"Medicine; Leukopenia; Neutropenia; Refractory (planetary science); Adverse effect; Glioma; Internal medicine; Oncolytic virus; Toxicity; Surgery; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":{"n_in":0,"stratum":"aff_core","weight":5595.2375,"opus":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Phase I clinical trial of an oncolytic virus therapy in pediatric brain tumors."},"gpt":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"This is a phase I clinical trial of a brain-tumor therapy, not metaresearch."},"grok":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Phase I clinical trial of oncolytic therapy in pediatric brain tumours."}}}